CHIKUNGUNYA
Clinical trials for CHIKUNGUNYA explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chikungunya vaccine enters first human safety trial
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new vaccine called PepGNP-ChikV, designed to protect against chikungunya virus. About 40 healthy adults aged 18-60 will receive two shots, 42 days apart, and be monitored for safety and immune response for a year. The study aims to see if the vaccin…
Matched conditions: CHIKUNGUNYA
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 09:56 UTC
-
Two-for-One vaccine shot? new study tests combined dengue and chikungunya protection
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether giving two live vaccines—one for dengue and one for chikungunya—at the same time is as safe and effective as giving them separately. About 900 adults aged 18 to 59 who have never been exposed to either virus will take part. The goal is to see if a single …
Matched conditions: CHIKUNGUNYA
Phase: PHASE3 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 09:55 UTC
-
Exercise program aims to ease long-term muscle problems after dengue and chikungunya
Symptom relief Not yet recruitingThis study tests a 20-session exercise program for adults who had dengue or chikungunya in the last five years. The goal is to see if supervised aerobic, anaerobic, and breathing exercises can improve muscle strength, reduce fatigue, and help with balance. 54 participants will be…
Matched conditions: CHIKUNGUNYA
Phase: NA • Sponsor: Universidade do Estado do Pará • Aim: Symptom relief
Last updated May 26, 2026 09:52 UTC